These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21718909)

  • 1. The lessons of COURAGE for the management of stable coronary artery disease.
    Kottke TE
    J Am Coll Cardiol; 2011 Jul; 58(2):138-9. PubMed ID: 21718909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology].
    Henderson RA; Timmis AD
    G Ital Cardiol (Rome); 2012 Apr; 13(4):244-53. PubMed ID: 22495641
    [No Abstract]   [Full Text] [Related]  

  • 3. On COURAGE and lessons from the heart.
    Awad I
    Neurosurgery; 2007 Jun; 60(6):N8. PubMed ID: 17546722
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
    Maron DJ; Boden WE; Spertus JA; Hartigan PM; Mancini GB; Sedlis SP; Kostuk WJ; Chaitman BR; Shaw LJ; Berman DS; Dada M; Teo KK; Weintraub WS; O'Rourke RA;
    J Am Coll Cardiol; 2011 Jul; 58(2):131-7. PubMed ID: 21718908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COURAGE to change practice? Revascularisation in patients with stable coronary artery disease.
    Fox KA
    Heart; 2009 May; 95(9):689-92. PubMed ID: 19240051
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is angioplasty in patients with stable coronary artery disease only a placebo? Absolutely not].
    Di Mario C; Chiriatti N; Stolcova M
    G Ital Cardiol (Rome); 2018 Nov; 19(11 Suppl 2):12S-13S. PubMed ID: 30520459
    [No Abstract]   [Full Text] [Related]  

  • 8. Almanac 2011: stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology.
    Henderson RA; Timmis AD
    Heart; 2011 Oct; 97(19):1552-9. PubMed ID: 21900584
    [No Abstract]   [Full Text] [Related]  

  • 9. The year in interventional cardiology.
    O'Neill WW; Dixon SR; Grines CL
    J Am Coll Cardiol; 2005 Apr; 45(7):1117-34. PubMed ID: 15808773
    [No Abstract]   [Full Text] [Related]  

  • 10. Do hybrid procedures have proven clinical utility and are they the wave of the future? : hybrid procedures have no proven clinical utility and are not the wave of the future.
    Leacche M; Zhao DX; Umakanthan R; Byrne JG
    Circulation; 2012 May; 125(20):2504-10; discussion 2510. PubMed ID: 22615421
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: One year perspective on COURAGE.
    Sedlis SP; Boden WE; Weintraub WS; Maron DS; O'Rourke RA; Berman DS; Mancini GB;
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):428. PubMed ID: 19133682
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiologists get wake-up call on stents.
    Mitka M
    JAMA; 2007 May; 297(18):1967-8. PubMed ID: 17488954
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database.
    McGuire DK; Anstrom KJ; Peterson ED
    Circulation; 2003 Apr; 107(14):1864-70. PubMed ID: 12668513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
    Kuller LH
    Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the metabolic syndrome and the incidence of stroke after complete coronary revascularization over a 10-year follow-up period.
    Kasai T; Miyauchi K; Kajimoto K; Kubota N; Yanagisawa N; Amano A; Daida H
    Atherosclerosis; 2009 Nov; 207(1):195-9. PubMed ID: 19501357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery disease: medical therapy is sometimes best. Invasive treatment is not always necessary; angioplasty may not offer any added advantage.
    Duke Med Health News; 2007 Jul; 13(7):3. PubMed ID: 17687788
    [No Abstract]   [Full Text] [Related]  

  • 17. The place of rotablator for treatment of in-stent restenosis.
    Reith S; Radke PW; Volk O; vom Dahl J; Klues HG
    Semin Interv Cardiol; 2000 Dec; 5(4):199-208. PubMed ID: 11244517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of metabolic syndrome and diabetes mellitus on cardiovascular events in coronary artery disease without ischemia on stress thallium-201 single photon emission computed tomography after percutaneous coronary intervention].
    Mori T; Ohashi Y; Ejiri J; Takatsuki K; Ichikawa S; Awano K
    J Cardiol; 2005 Sep; 46(3):89-96. PubMed ID: 16218426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery restenosis: a paradigm of current treatment approaches.
    Kiernan TJ; Kiernan GD; Yan BD
    Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.
    Torosoff MT; Sidhu MS; Desai KP; Fein SA; Boden WE
    J Comp Eff Res; 2015 Sep; 4(5):505-14. PubMed ID: 26387530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.